AnimalBiome is a pioneering company in the field of microbiome science for companion animals, focusing on the gut health of pets such as cats and dogs. The company operates in the pet healthcare market, providing DNA sequencing-based tests to detect bacterial imbalances and identify specific harmful and beneficial bacteria in the gut. AnimalBiome serves pet owners and veterinary professionals who are looking for science-backed solutions to improve the health and wellbeing of their pets. The business model revolves around selling gut health tests and treatments directly to consumers through their website, as well as partnering with veterinary clinics. Revenue is generated from the sale of these products and services, with additional income from an affiliate program that rewards community members for promoting their offerings. The company leverages advanced DNA sequencing technology and sophisticated software to analyze over 5,000 different types of gut bacteria, providing actionable insights to pet owners. Founded by Holly Ganz and led by CEO Carlton Osborne, AnimalBiome has grown significantly since its inception, driven by a team of passionate scientists and pet lovers.

Keywords: microbiome, gut health, DNA sequencing, pets, cats, dogs, bacterial imbalance, veterinary, health tests, treatments